Eli Lilly Abandons Development of New Cholesterol Drug
Eli Lilly Ceased Work For New Cholesterol Drug. Drug maker Eli Lilly announced that it was ceasing work on a new cholesterol-lowering drug, after the drug failed to perform well in a phase 3 clinical trial. The drug, evacetrapib, was designed to prevent heart attacks and other cardiovascular problems by modifying cholesterol … [Read more...] about Eli Lilly Abandons Development of New Cholesterol Drug
Avandia Most Adverse Event Report
Avandia, Seroquel Adverse Events. Avandia’s cardiovascular problems have long been the subject of concern and controversy. Now, reports FiercePharma, an adverse event (AE) report for last year’s third quarter indicated that GlaxoSmithKline’s Avandia (generic: rosiglitazone) was number one on the list. The Institute for Safe … [Read more...] about Avandia Most Adverse Event Report
DIABETICS FACE INCREASED RISK OF HEART DISEASE FROM AIR POLLUTION
Diabetics May Be At Higher Risk For Cardiovascular Problems From Air Pollution. A study of Boston area residents conducted by researchers at the Harvard School of Public Health and funded by the National Institute of Environmental Health Sciences (one of the National Institutes of Health) suggests that diabetics may be at higher risk … [Read more...] about DIABETICS FACE INCREASED RISK OF HEART DISEASE FROM AIR POLLUTION
